再鼎医药（09688）今日盘中大涨8.03%，领涨港股生物医药板块。该板块整体表现活跃，多只个股出现明显上涨。
据市场消息，荣昌生物、诺诚健华等公司股价涨幅超过6%，药明康德涨超4%，康方生物涨近4%，金斯瑞生物科技、君实生物、百济神州等公司股价也有2%以上的涨幅。生物医药板块的全面走强带动了再鼎医药股价的大幅上涨。
分析人士认为，近期美国总统特朗普宣布将对非美国本土生产的医药产品征收100%关税的消息，可能对行业产生深远影响。西南证券指出，这一政策短期内影响可能有限，但长期来看可能推动创新药企业更多地选择license-out模式，加强国际合作，并促使企业更加注重开发具有显著临床价值的First-in-Class和Best-in-Class药物。这一趋势可能有利于像再鼎医药这样的创新型生物医药企业，从而推动其股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.